Hal Mintz serves as Executive at Celsus Therapeutics Plc., where they oversee executive responsibilities. Since joining the company, Hal Mintz has executed 3 insider transactions totaling $13.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 11, 2014 involved purchasing 100 shares valued at $515.
Hal Mintz currently holds 757,930 shares of Celsus Therapeutics Plc. (CLTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Hal Mintz has been a net buyer of CLTX stock. They have purchased $13.8K and sold $0 worth of shares.
Hal Mintz's most recent insider trade was on Apr 11, 2014, when they purchased 100 shares at $5.15 per share.
Get notified when new Form 4 filings are submitted
| $5.25 |
| Discretionary |
| Apr 9, 2014 | CLTX | $5.9K | Purchase | 1,075 | $5.51 | Discretionary |